Мадридте ең жақсы онкологияның онкологтар - ЖОҒ-8 дәрігерлер

Доктор Арес протонды терапия саласындағы әлемдік көшбасшы – Quironsalud протонды терапия орталығында радиациялық онкология бөлімшесін басқарады.

• Ісіктерді дәл нысанаға алу үшін протонды терапия бойынша 15 жылдан астам мамандану
• Массачусетс жалпы ауруханасының протонды терапия орталығында білім алған
• Рецензияланатын журналдарда 34-тен астам ғылыми еңбектерін жариялаған
• Испанияның жетекші протонды терапия орталығының бөлім меңгерушісі

Доктор Мазаль 30 жылдан астам уақыт бойы Кюри институтының Протондық терапия орталығында техникалық директор болып жұмыс істеп, жаһандық деңгейде протондық терапия әдістерінің негізін қалады.

• Радиациялық онкология саласындағы 140-тан астам ғылыми жарияланым
• PTCOG – бөлшектер терапиясы бойынша жетекші зерттеу тобының төрағасы
• Дүниежүзілік протон орталықтарында қолданылатын хаттамаларды әзірледі
• 10-нан астам елдегі емдеу орталықтарына кеңес береді
• Жоғары технологиялық терапияларды зерттеуге 50 миллион еуродан астам қаржы тартты

Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.

He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Доктор Лопес Ибор HM Montepríncipe ауруханасындағы балалар гематологиясы және онкологиясы бөлімшесін басқарады, оның балалар қатерлі ісігі саласында 20 жылдан астам тәжірибесі бар.

• Сүйек және ми ісіктері, лейкемия және гематологиялық ауруларға маманданған
• Мэриленд университетінде балалар гематологиясы және онкологиясы бойынша дайындықтан өткен
• Көптеген ұлттық және халықаралық ғылыми жарияланымдардың авторы
• Бұған дейін Clínica San Rafael клиникасында балалар онкологиясын басқарған

Клиникалық және қолданбалы онкология саласындағы дипломнан кейінгі зерттеулердің директоры – доктор Кубильо Грасиан ас қорыту жүйесінің қатерлі ісігін емдей отырып, HM CIOCC-та болашақ мамандарды даярлайды.

• Ас қорыту мүшелерінің ісіктері мен ұйқы безінің нейроэндокриндік ісіктеріне маманданған
• USP CEU университетінде онкология курстарынан сабақ береді
• М.Д. Андерсон атындағы онкологиялық орталығында білім алған
• Ас қорыту жүйесінің патологиясы бойынша халықаралық курстарды басқарады